PATENT CLAIM ANALYSIS

Application Number: 15764730
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "004900"]

Abstract:
The disclosure is related to a method of treating a disorder, such as obesity or a condition associated with obesity, such as hyperphagia, in a subject using a melanocortin-4 receptor (MC4R) agonist.

Claim (Index 14):
The method of  claim 9 , wherein the MC4R agonist is administered in an amount sufficient to decrease appetite in the subject without compromising body weight.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775916', '14800627', '15442229', '13057966', '13074565']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8212315808568698
- 35 USC 102 Novelty (BERT): 0.544242505040899
- Combined Prediction Score: 0.7935326732752728
- Mean Citation Score: 408.489952
- Max Citation Score: 437.57434000000006
- Similarity Product: 233.5582501370716

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test